Central Proteina Prima Tbk. vs Uni-Charm Indonesia Tbk. — how do they compare? Central Proteina Prima Tbk. trades at Rp50 (market cap 2.98T, 2.22M 24h volume), while Uni-Charm Indonesia Tbk. trades at Rp380 (market cap 1.58T, 195.4K 24h volume). The key difference: Central Proteina Prima Tbk. is the larger of the two by market cap, and Central Proteina Prima Tbk. is more actively traded (2.22M versus 195.4K). Which is the better fit depends on your goals.
| CPRO | UCID | |
|---|---|---|
Market Cap | 2.98T | 1.58T |
Volume | 2.22M | 195.4K |
Lot | 22.16K | 1.95K |
Turnover | 110.81M | 74.43M |
Average Price | 50 | 380.89 |
Value | 110.81M | 74.43M |
Indicative Equilibrium Price | 50 | 380 |
Indicative Equilibrium Volume | 32 | 5 |
Trailing returns across standard periods
Latest headlines on both assets
PT Central Proteinprima Tbk (The Company) was established on April 30, 1980 based on the Domestic Capital Investment Law No. 6 year 1968. Base on notarial deed no. 45 dated Dec 7, 1989 the company's share holders agreed offering 1.000.000 share to public, increase paid up capital and authorized capital. At 14 May 1990, the company's shares were treadeable in Jakarta Stock Exchange.Base on notarial deed no.7 dated 4 Oct 2004 of Fahiah Helmi, SH, the company was changed to private company. At Nov 5, 2004, base on JSX letter no S-1671/BEJ-PSR/11-2004 the company was delisted. And then at Sep 2004, the Company's ownership was changed to foreign investment. The Company’s articles of association has been amended several times, most recently by notarial deed No. 57 of Lies Herminingsih, S.H., dated Sep 30, 2006, concerning change of director's job description.
Read more on CPRO →PT Uni-Charm Indonesia Tbk (the Company) was established based on Notarial Deed No. 37 dated 5 June 1997 of Linda Herawati S.H. The Company commenced its commercial operation in February 1998. The Company and its Subsidiary (the Group) operates under Unicharm Group. The ultimate parent of the Group is Unicharm Corporation, domiciled in Japan.
Read more on UCID →